Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • blank2thisone blank2thisone Sep 13, 2013 5:40 PM Flag

    President of NTM info & research (about Arikace)

    “Arikace has several advantages over Amikacin, including a longer half life, and possibly a greater ability to penetrate both biofilms and macrophages, which may make the drug more effective. Although these expectations need to be verified in the clinical trial, I am truly excited by what I have been told,” he added.

    Sentiment: Strong Buy

 
INSM
22.12-0.49(-2.17%)May 26 4:00 PMEDT